胶质瘤女性的生育力保存结局:一项回顾性病例对照研究
2007至2018年在布莱根妇女医院纳入10例胶质瘤化疗和/或放疗前接受生育力保存的患者,按年龄±1岁以1:3匹配男性因素不孕对照。胶质瘤患者基线抗苗勒管激素显著低于对照(2.37 vs 5.16 ng/mL,p=0.002,对数转换),促性腺激素起始及总剂量更高、雌二醇峰值更低,但获卵数、成熟卵母细胞比例等与对照相似;1例患者移植冻存胚胎后足月分娩健康婴儿。
要点
- 胶质瘤患者生育力保存前基线抗苗勒管激素显著低于男性因素不孕对照。
- 胶质瘤患者需更高促性腺激素剂量,但获卵数与成熟卵母细胞比例与对照相似。
- 1例患者移植冻存胚胎后分娩健康婴儿。
核心结论
- 胶质瘤患者在化疗和/或放疗前接受生育力保存可获得满意的生育力保存结局,应就此适当告知其治疗后组建家庭的机会。
研究设计与样本
- 回顾性病例对照研究,2007至2018年在布莱根妇女医院纳入10例胶质瘤化疗和/或放疗前接受生育力保存的患者,按年龄±1岁以1:3匹配男性因素不孕对照。
主要发现
- 胶质瘤患者基线抗苗勒管激素显著低于男性因素不孕对照(2.37 vs 5.16 ng/mL,p=0.002,对数转换)。
- 胶质瘤患者起始促性腺激素剂量(350 vs 240 IU,p=0.004)和总剂量(4270 vs 2270 IU,p<0.001)均高于对照,刺激持续时间相似(12.1 vs 11.1天,p=0.219)。
- 胶质瘤患者雌二醇峰值低于对照(1420 vs 2245 pg/mL,p=0.003)。
- 触发日总卵泡数(14.1 vs 15.6,p=0.284)、获卵数(18.4 vs 20.5,p=0.618)和成熟卵母细胞百分比(69.9 vs 73.8%,p=0.076)在两组间相似。
- 1例患者返回接受冻存胚胎移植并分娩一健康婴儿。
临床怎么用
- 作者认为,胶质瘤患者在化疗和/或放疗前接受生育力保存可获得满意的生育力保存结局,应就此适当告知其治疗后组建家庭的机会。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: With advances in cancer therapy, reproductive-aged women can look forward to a life post-malignancy. Fortunately, fertility preservation (FP) may provide relief from potential infertility caused by cancer or associated caustic treatments. Outcomes of FP in pre-treatment reproductive-aged women with gliomas have not been previously characterized. METHODS: Between 2007 and 2018, 10 patients undergoing FP prior to chemotherapy and/or radiation treatment for gliomas were identified at Brigham and Women's Hospital. They were matched 3:1 to male-factor infertility patients by age ± 1 year. RESULTS: Patients with gliomas had significantly lower baseline anti-Müllerian hormone levels than male-factor infertility controls (2.37 vs 5.16 ng/mL, p = 0.002, log transformed). Despite higher starting (350 vs. 240 IU, p = 0.004) and total gonadotropin doses (4270 vs. 2270 IU, p < 0.001) over a similar stimulation duration (12.1 vs. 11.1 days, p = 0.219), cancer patients had lower peak estradiol levels (1420 vs. 2245 pg/mL, p = 0.003). The total number of follicles on the day of trigger (14.1 vs. 15.6, p = 0.284), the number of oocytes retrieved (18.4 vs. 20.5, p = 0.618), and the percentage of mature oocytes (69.9 vs. 73.8%, p = 0.076) were similar between cases and controls. One patient returned for a cryopreserved embryo transfer and delivered a healthy child. CONCLUSIONS: Patients undergoing FP prior to chemotherapy and/or radiation for a glioma achieve satisfactory FP outcomes and should be appropriately counseled regarding the opportunity to family-build after treatment.
引用
- Nordan T, Thomas AM, Ginsburg ES, et al. Fertility preservation outcomes in women with gliomas: a retrospective case-control study. J Neurooncol. 2020. PMID: 32060839. doi:10.1007/s11060-020-03429-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。